Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | SARS-CoV-2 | Research article

Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above

Authors: Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, Hamda Abdulla A/Qotba, Gheyath K. Nasrallah, Asmaa A. Althani, Hadi M. Yassine, Abduljaleel Abdullatif Zainel, Hanan Khudadad, Tamara Marji, Shajitha Thekke Veettil, Hadeel T. Al-Jighefee, Salma Younes, Farah Shurrab, Duaa W. Al-Sadeq, Al Anoud Saleh AlFehaidi, Ameena Ibrahim Yfakhroo, Meshal Abdulla AlMesaifri, Hanan Al Mujalli, Samya Ahmad Al Abdulla, Mohamed Ghaith Al Kuwari, Faruk Mohammed Azad, Badria Ali Mohamed Al Malki, Mariam Ali Abdulmalik

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design and reports findings of a population based epidemiological study undertaken to characterise SARS-CoV2 in Qatar using limited resources in a timely manner.

Methods

Asymptomatic individuals ≥10 years registered with Qatar’s publicly funded primary health provider were eligible. A stratified random sampling technique was utilized to identify the study sample. Participants were invited to an appointment where they completed a questionnaire and provided samples for polymerase chain reaction and Immunoglobulin M and G immunoassay tests. Data collected were analyzed to calculate point and period prevalence by sociodemographic, lifestyle and clinical characteristics.

Results

Of 18,918 individuals invited for the study, 2084 participated (response rate 10.8%). The overall point prevalence and period prevalence were estimated to be 1.6% (95% CI 1.1–2.2) and 14.6% (95% CI 13.1–16.2) respectively. Period prevalence of SARS-CoV2 infection was not considerably different across age groups (9.7–19.8%). It was higher in males compared to females (16.2 and 12.7% respectively). A significant variation was observed by nationality (7.1 to 22.2%) and municipalities (6.9–35.3%).

Conclusions

The study provides an example of a methodologically robust approach that can be undertaken in a timely manner with limited resources. It reports much-needed epidemiological data about the spread of SARS-CoV2. Given the low prevalence rates, majority of the population in Qatar remains susceptible. Enhanced surveillance must continue to be in place, particularly due to the large number of asymptomatic cases observed. Robust contact tracing and social distancing measures are key to prevent future outbreaks.
Appendix
Available only for authorised users
Literature
10.
go back to reference Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759–65.CrossRef Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759–65.CrossRef
15.
go back to reference Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 14]. Postgrad Med. 2020:1–7. Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 14]. Postgrad Med. 2020:1–7.
Metadata
Title
Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above
Authors
Mohamed Ahmed Syed
Ahmed Sameer Al Nuaimi
Hamda Abdulla A/Qotba
Gheyath K. Nasrallah
Asmaa A. Althani
Hadi M. Yassine
Abduljaleel Abdullatif Zainel
Hanan Khudadad
Tamara Marji
Shajitha Thekke Veettil
Hadeel T. Al-Jighefee
Salma Younes
Farah Shurrab
Duaa W. Al-Sadeq
Al Anoud Saleh AlFehaidi
Ameena Ibrahim Yfakhroo
Meshal Abdulla AlMesaifri
Hanan Al Mujalli
Samya Ahmad Al Abdulla
Mohamed Ghaith Al Kuwari
Faruk Mohammed Azad
Badria Ali Mohamed Al Malki
Mariam Ali Abdulmalik
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06251-z

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue